Cargando…

Patient and physician preferences for ulcerative colitis treatments in the United States

Purpose: This study aimed to elicit patient and physician preferences for ulcerative colitis (UC) treatments in the United States (US). Patients and methods: The following UC treatment attributes included in the discrete-choice experiment (DCE) were identified during qualitative interviews with both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boeri, Marco, Myers, Kelley, Ervin, Claire, Marren, Amy, DiBonaventura, Marco, Cappelleri, Joseph C, Hauber, Brett, Rubin, David T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572717/ https://www.ncbi.nlm.nih.gov/pubmed/31354328 http://dx.doi.org/10.2147/CEG.S206970

Ejemplares similares

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
por: Armuzzi, Alessandro, et al.
Publicado: (2020)

The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe
por: Armuzzi, Alessandro, et al.
Publicado: (2020)

Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review
por: Yarlas, Aaron, et al.
Publicado: (2018)

Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis
por: Brookes, Matthew J, et al.
Publicado: (2020)

Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies
por: Dubinsky, Marla C, et al.
Publicado: (2020)

Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View
por: Dubinsky, Marla C, et al.
Publicado: (2021)

Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States
por: Long, Millie D, et al.
Publicado: (2020)

Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis
por: Wu, Jashin J., et al.
Publicado: (2022)

Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis
por: Walsh, David A., et al.
Publicado: (2022)

Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis
por: Long, Millie D., et al.
Publicado: (2022)

Gastroenterologists’ Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey
por: Lasch, Karen, et al.
Publicado: (2016)

Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program
por: Dubinsky, Marla C., et al.
Publicado: (2023)

1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States
por: Vietri, Jeffrey T, et al.
Publicado: (2023)

Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians
por: Rubin, David T, et al.
Publicado: (2020)

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data
por: Curtis, Jeffrey R, et al.
Publicado: (2020)

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Qian, Yi, et al.
Publicado: (2018)

From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices
por: Boeri, Marco, et al.
Publicado: (2019)

Burden of peripheral arterial disease in Europe and the United States: a patient survey
por: Marrett, Elizabeth, et al.
Publicado: (2013)

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia
por: Graham-Clarke, Peita L, et al.
Publicado: (2020)

Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study
por: Ren, Jinma, et al.
Publicado: (2023)

The association of sleep difficulties with health-related quality of life among patients with fibromyalgia
por: Wagner, Jan-Samuel, et al.
Publicado: (2012)

The association between lower back pain and health status, work productivity, and health care resource use in Japan
por: Sadosky, Alesia B, et al.
Publicado: (2015)

Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database
por: Eichenfield, Lawrence F., et al.
Publicado: (2020)

Epidemiology of physician-diagnosed neuropathic pain in Brazil
por: Udall, Margarita, et al.
Publicado: (2019)

Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam
por: Kudel, Ian, et al.
Publicado: (2019)

Vaccination Rates among the General Adult Population and High-Risk Groups in the United States
por: Annunziata, Kathy, et al.
Publicado: (2012)

Humanistic and economic burden of fibromyalgia in Japan
por: Lee, Lulu K, et al.
Publicado: (2016)

The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer
por: Hauber, Brett, et al.
Publicado: (2020)

Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials
por: Katz, Eva G, et al.
Publicado: (2016)

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
por: Panaccione, Remo, et al.
Publicado: (2020)

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
por: Mahadevan, Uma, et al.
Publicado: (2018)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
por: Patel, Haridarshan, et al.
Publicado: (2017)

Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials
por: Panaccione, Remo, et al.
Publicado: (2020)

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2013)

Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient–Physician Visits
por: Rubin, David T., et al.
Publicado: (2017)

Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment
por: McErlane, Flora, et al.
Publicado: (2023)

Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
por: González, Juan Marcos, et al.
Publicado: (2017)

Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey
por: Odufalu, Florence-Damilola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_spkm91dbmhtusvoin0ruv4ibap